Incyte Financial Ratios
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Incyte ratio analysis
Incyte earned a net margin of 25.0% in FY 2025, up from 0.8% a year earlier. Gross margin was 92.8% compared with a median of 94.7% over the prior 9 years. Return on equity reached 24.9%, meaning Incyte generated 0.25 dollars of profit for every dollar of shareholders' equity.
At the end of FY 2025, INCY traded at 15.8 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 15.8 to 464.2, with a median of 45.4. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Incyte financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 15.82 | 464.20 | 23.69 | 52.84 | 17.19 | — | 38.00 | 141.71 | — | 185.69 |
| Price / sales | 3.85 | 3.40 | 3.80 | 5.25 | 5.42 | 7.11 | 7.76 | 8.16 | 12.61 | 17.04 |
| Price / book | 3.83 | 4.18 | 2.71 | 4.08 | 4.29 | 7.26 | 6.44 | 7.97 | 11.88 | 44.91 |
| Gross margin | 92.8% | 92.6% | 93.1% | 93.9% | 94.9% | 95.1% | 94.7% | 95.0% | 94.8% | 94.7% |
| Operating margin | 29.5% | 1.4% | 16.8% | 17.1% | 19.6% | -9.9% | 18.6% | 6.9% | -15.8% | 13.1% |
| Net margin | 25.0% | 0.8% | 16.2% | 10.0% | 31.8% | -11.1% | 20.7% | 5.8% | -20.4% | 9.4% |
| Free cash flow margin | 27.5% | 7.9% | 13.4% | 26.3% | 19.0% | -11.7% | 29.3% | 14.0% | -13.3% | 16.7% |
| Return on equity (ROE) | 24.9% | 0.9% | 11.5% | 7.8% | 25.2% | -11.3% | 17.2% | 5.7% | -19.2% | 24.8% |
| Return on assets (ROA) | 18.5% | 0.6% | 8.8% | 5.8% | 19.2% | -8.3% | 13.0% | 4.1% | -13.6% | 6.4% |
| Debt / equity | — | — | — | — | — | — | — | 9.91 | 0.02 | 1.79 |
| Current ratio | 3.32 | 1.97 | 3.75 | 3.54 | 3.65 | 3.74 | 4.83 | 4.31 | 4.01 | 3.64 |
| Revenue growth | 21.2% | 14.8% | 8.9% | 13.7% | 12.0% | 23.5% | 14.7% | 22.5% | 38.9% | 46.7% |
| EPS growth | 4,173.3% | -94.3% | 74.3% | -64.4% | — | -166.3% | 302.0% | — | -383.3% | 1,700.0% |